MidnightTrader

[TimChallenge] CLCD already peaked at 20.34 p/m and is dropping although it may find support in the low 18's

rpdata

[TimChallenge] CLCD announces achievement of both primary and key secondary endpoints in the samurai phase 3 pivotal trial of lasmiditan in migraine

Page
of 3